PriceTargets.com logo

NASDAQ:DHC - Diversified Healthcare Trust Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $4.60
  • Forecasted Upside: 20.10 %
  • Number of Analysts: 5
  • Breakdown:
  • 2 Sell Ratings
  • 2 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$3.83 As of 10/20/2021 01:00 AM ET
▲ +0.14 (3.79%)

This chart shows the closing price for DHC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Diversified Healthcare Trust Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DHC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DHC

Analyst Price Target is $4.60
▲ +20.10% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Diversified Healthcare Trust in the last 3 months. The average price target is $4.60, with a high forecast of $6.00 and a low forecast of $3.25. The average price target represents a 20.10% upside from the last price of $3.83.

This chart shows the closing price for DHC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 5 contributing investment analysts is to hold stock in Diversified Healthcare Trust. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 3 sell ratings
Ratings as of
4/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 3 sell ratings
Ratings as of
7/27/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
10/25/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 3 sell ratings
Ratings as of
1/23/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 3 sell ratings
Ratings as of
4/23/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
7/22/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
9/20/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
10/20/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/29/2021Morgan StanleyLower Price TargetEqual Weight$5.00 ➝ $4.75Low
7/16/2021Colliers SecuritiesReiterated RatingHold$5.00High
3/15/2021Morgan StanleyBoost Price TargetEqual Weight$4.75 ➝ $5.00Low
3/1/2021B. RileyBoost Price TargetBuy$5.00 ➝ $6.00Low
2/2/2021Morgan StanleyLower Price TargetEqual Weight$5.00 ➝ $4.75Low
12/10/2020Wells Fargo & CompanyDowngradeEqual Weight ➝ Underweight$4.00High
11/16/2020Bank of AmericaBoost Price TargetUnderperform$2.75 ➝ $3.25Low
10/9/2020Morgan StanleyBoost Price TargetEqual Weight$2.75 ➝ $3.00Low
6/22/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$3.50 ➝ $4.00Low
6/19/2020Wells Fargo & CompanyReiterated RatingHoldLow
6/8/2020JMP SecuritiesInitiated CoverageMarket PerformHigh
5/19/2020Morgan StanleyLower Price TargetEqual Weight$8.00 ➝ $2.75High
5/19/2020Royal Bank of CanadaLower Price TargetUnderperform$7.00 ➝ $3.00High
5/11/2020B. RileyLower Price TargetBuy$10.00 ➝ $7.00High
4/28/2020Wells Fargo & CompanyReiterated RatingHoldHigh
3/9/2020Royal Bank of CanadaReiterated RatingSell$7.00High
3/4/2020B. RileyLower Price TargetBuy$12.00 ➝ $10.00Medium
1/17/2020Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$9.00High
1/7/2020Raymond JamesUpgradeUnderperform ➝ Market PerformLow
10/14/2019Bank of AmericaInitiated CoverageUnderperformLow
9/6/2019Morgan StanleyInitiated CoverageUnderweight ➝ Equal Weight$8.50Low
4/4/2019B. RileySet Price TargetBuy$14.00Low
4/2/2019Royal Bank of CanadaDowngradeSector Perform ➝ Underperform$8.00High
3/28/2019Morgan StanleySet Price TargetSell$11.00Low
12/20/2018FBR & Co.Set Price TargetBuy$24.00Low
12/3/2018Wells Fargo & CompanyUpgradeMarket Perform ➝ OutperformLow
11/16/2018Jefferies Financial GroupDowngradeHold ➝ UnderperformHigh
11/12/2018B. RileyLower Price TargetBuy ➝ Buy$23.00 ➝ $21.00Medium
11/6/2018B. RileySet Price TargetBuy$23.00Low
10/29/2018Morgan StanleyDowngradeEqual Weight ➝ Underweight$17.00 ➝ $15.00Medium
8/8/2018B. RileyBoost Price TargetBuy ➝ Buy$22.00 ➝ $23.00Low
7/20/2018Jefferies Financial GroupReiterated RatingHoldLow
5/9/2018B. RileySet Price TargetBuy$22.00Low
3/20/2018Wells Fargo & CompanyLower Price TargetUnderperform ➝ Underperform$17.50 ➝ $16.00Low
3/8/2018Bank of AmericaLower Price TargetUnderperform ➝ Underperform$16.50 ➝ $16.00Low
3/1/2018B. RileySet Price TargetBuy ➝ Buy$24.00 ➝ $22.00Medium
2/28/2018Robert W. BairdSet Price TargetHold$17.00Low
2/28/2018Cantor FitzgeraldLower Price TargetOverweight ➝ Overweight$24.00 ➝ $21.00Low
2/21/2018Cantor FitzgeraldReiterated RatingBuyLow
1/24/2018B. RileySet Price TargetBuy$24.00Low
1/5/2018Robert W. BairdReiterated RatingNeutral ➝ Neutral$20.00 ➝ $19.00High
11/24/2017Robert W. BairdReiterated RatingHold$20.00N/A
11/13/2017B. RileyReiterated RatingBuy$24.00N/A
11/3/2017Robert W. BairdReiterated RatingHold$21.00N/A
11/1/2017B. RileyReiterated RatingBuyN/A
10/3/2017Jefferies Financial GroupReiterated RatingHold$20.00Low
10/2/2017UBS GroupLower Price TargetNeutral$20.00 ➝ $19.00Low
9/25/2017Morgan StanleyBoost Price TargetEqual Weight$18.50 ➝ $19.50Low
9/13/2017Royal Bank of CanadaReiterated RatingHold$20.00Low
7/24/2017Royal Bank of CanadaReiterated RatingHold$22.00Low
6/30/2017FBR & Co.Reiterated RatingBuy$24.00Low
6/19/2017Royal Bank of CanadaReiterated RatingHold$22.00Low
6/9/2017Cantor FitzgeraldReiterated RatingBuy$24.00Low
5/15/2017Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$24.00 ➝ $22.00High
5/12/2017Jefferies Financial GroupReiterated RatingHold$21.00Medium
5/8/2017FBR & Co.Reiterated RatingBuyLow
3/10/2017Robert W. BairdInitiated CoverageNeutralLow
3/9/2017Robert W. BairdInitiated CoverageNeutral ➝ Neutral$20.00Low
2/28/2017Cantor FitzgeraldReiterated RatingBuy$24.00N/A
1/3/2017Royal Bank of CanadaSet Price TargetBuy$24.00N/A
12/28/2016Cantor FitzgeraldInitiated CoverageOverweight$23.00N/A
12/21/2016FBR & Co.Reiterated RatingOutperformN/A
12/21/2016FBR & Co.Initiated CoverageOutperform$24.00N/A
12/19/2016Jefferies Financial GroupReiterated RatingHold$19.00N/A
12/13/2016Wells Fargo & CompanyDowngradeMarket Perform ➝ UnderperformN/A
10/20/2016Jefferies Financial GroupDowngradeBuy ➝ Hold$25.00 ➝ $23.00N/A
(Data available from 10/20/2016 forward)

News Sentiment Rating

1.19 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/24/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/23/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/23/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/22/2021
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/22/2021
  • 5 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/21/2021
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/20/2021
  • 4 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/20/2021

Current Sentiment

  • 4 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

Diversified Healthcare Trust logo
Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants. The SHOP segment manages senior living communities that offers short term and long term residential care, and other services for residents where it pay fees to the operator to manage the communities for its account. The company was founded on December 16, 1998 and is headquartered in Newton, MA.
Read More

Today's Range

Now: $3.83
Low: $3.67
High: $3.84

50 Day Range

MA: $3.59
Low: $3.39
High: $3.87

52 Week Range

Now: $3.83
Low: $2.85
High: $5.58

Volume

868,445 shs

Average Volume

1,218,744 shs

Market Capitalization

$912.98 million

P/E Ratio

N/A

Dividend Yield

1.08%

Beta

1.39

Frequently Asked Questions

What sell-side analysts currently cover shares of Diversified Healthcare Trust?

The following Wall Street sell-side analysts have issued reports on Diversified Healthcare Trust in the last year: B. Riley, Bank of America Co., Colliers Securities, Morgan Stanley, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for DHC.

What is the current price target for Diversified Healthcare Trust?

5 Wall Street analysts have set twelve-month price targets for Diversified Healthcare Trust in the last year. Their average twelve-month price target is $4.60, suggesting a possible upside of 24.7%. B. Riley has the highest price target set, predicting DHC will reach $6.00 in the next twelve months. Bank of America Co. has the lowest price target set, forecasting a price of $3.25 for Diversified Healthcare Trust in the next year.
View the latest price targets for DHC.

What is the current consensus analyst rating for Diversified Healthcare Trust?

Diversified Healthcare Trust currently has 2 sell ratings, 2 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in DHC, but not buy more shares or sell existing shares.
View the latest ratings for DHC.

What other companies compete with Diversified Healthcare Trust?

Other companies that are similar to Diversified Healthcare Trust include American Tower, Public Storage, Welltower, Weyerhaeuser, Extra Space Storage, Ventas, Medical Properties Trust, CubeSmart, Life Storage, Omega Healthcare Investors, Rayonier, Healthcare Realty Trust, Ryman Hospitality Properties, EPR Properties and PotlatchDeltic.

How do I contact Diversified Healthcare Trust's investor relations team?

Diversified Healthcare Trust's physical mailing address is Two Newton Place 255 Washington Street Suite 300, NEWTON MA, 02458. The real estate investment trust's listed phone number is (617) 796-8350 and its investor relations email address is [email protected] The official website for Diversified Healthcare Trust is www.dhcreit.com.